Metraipolis › archive › dc_034659f53126

Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease — Europe PMC PMID:41348991

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41348991
DOI
10.1021/acs.jmedchem.5c01425
License (as archived)
solo-consultazione
Archived
2026-11-07T21:56:50.074Z
SHA-256 of the archived text
4b9aa9c613dfaa24c376b3a6b6dea8b799003cad8348a54ab8fdc0140289328e
Stable URL of this page
https://metraipolis.com/documento/dc_034659f53126

How to cite

Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease — Europe PMC PMID:41348991 — Europe PMC (en), https://europepmc.org/article/MED/41348991 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_034659f53126 (Metraipolis archive dc_034659f53126, sha256 4b9aa9c613dfaa24c376b3a6b6dea8b799003cad8348a54ab8fdc0140289328e)
BibTeX
@misc{dc034659f53126,
  title = {Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease — Europe PMC PMID:41348991},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41348991},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_034659f53126; sha256 4b9aa9c613dfaa24c376b3a6b6dea8b799003cad8348a54ab8fdc0140289328e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41348991. Agents can read the archived copy with the MCP tool read_document.